Less Intensive Regimens May Still Be Suitable for the Initial Treatment of Primary Mediastinal B-Cell Lymphoma in Resource-Limited Settings

Table 3

Proportion of patients who received dose escalation in DA-EPOCH-R group (n = 39).

Level	n	%
1	10	25.6
2	8	20.6
3	10	25.6
4	10	25.6
5	1	2.6

Dose escalation: levels 2 to 5, according to Dunleavy et al., NEJM, 2013.